These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15877070)

  • 1. Bringing amyloid into focus.
    Golde TE; Bacskai BJ
    Nat Biotechnol; 2005 May; 23(5):552-4. PubMed ID: 15877070
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe.
    Hintersteiner M; Enz A; Frey P; Jaton AL; Kinzy W; Kneuer R; Neumann U; Rudin M; Staufenbiel M; Stoeckli M; Wiederhold KH; Gremlich HU
    Nat Biotechnol; 2005 May; 23(5):577-83. PubMed ID: 15834405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and Alzheimer disease: the good, the bad, and the ugly.
    Weninger SC; Yankner BA
    Nat Med; 2001 May; 7(5):527-8. PubMed ID: 11329045
    [No Abstract]   [Full Text] [Related]  

  • 5. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
    Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
    Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
    Elsinghorst PW; Härtig W; Goldhammer S; Grosche J; Gütschow M
    Org Biomol Chem; 2009 Oct; 7(19):3940-6. PubMed ID: 19763296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
    Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
    Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linker histone H1 binds to disease associated amyloid-like fibrils.
    Duce JA; Smith DP; Blake RE; Crouch PJ; Li QX; Masters CL; Trounce IA
    J Mol Biol; 2006 Aug; 361(3):493-505. PubMed ID: 16854430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
    Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced circulating angiogenic cells in Alzheimer disease.
    Brenner SR; Roh JK; Lee ST; Chu K; Jung KH; Lee SK; Kim M
    Neurology; 2010 Jan; 74(4):346; author reply 346-7. PubMed ID: 20101043
    [No Abstract]   [Full Text] [Related]  

  • 16. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.
    Nilsson KP; Aslund A; Berg I; Nyström S; Konradsson P; Herland A; Inganäs O; Stabo-Eeg F; Lindgren M; Westermark GT; Lannfelt L; Nilsson LN; Hammarström P
    ACS Chem Biol; 2007 Aug; 2(8):553-60. PubMed ID: 17672509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on distribution of neural stem cells in the brain of Alzheimer disease transgenic mice through caudal vein transplantation].
    Zhan YQ; Wang FR; Li FG; Xing BZ; Fang X; Zhang SM
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1786-8. PubMed ID: 17919390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.
    Lee KW; Im JY; Song JS; Lee SH; Lee HJ; Ha HY; Koh JY; Gwag BJ; Yang SD; Paik SG; Han PL
    Neurobiol Dis; 2006 Apr; 22(1):10-24. PubMed ID: 16289866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary characterization of long-term reaggregating cultures of trisomy 16 central nervous system.
    Bredesen DE; Kane DJ; Holtzman DM; Epstein CJ
    Prog Clin Biol Res; 1992; 379():259-70. PubMed ID: 1409749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.